NanJing Pharmaceutical Co Ltd (600713) — Cash Flow Quality Index
NanJing Pharmaceutical Co Ltd (600713) has a Cash Flow Quality Index of -8.52x as of September 2025. Operating cash flow of CN¥-942.93 Million is below net income of CN¥110.69 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore NanJing Pharmaceutical Co Ltd (600713) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
NanJing Pharmaceutical Co Ltd Cash Flow Quality Index (1998–2024)
Historical Cash Flow Quality Index for NanJing Pharmaceutical Co Ltd across 24 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how aggressively does NanJing Pharmaceutical Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for NanJing Pharmaceutical Co Ltd (1998–2024)
Year-by-year earnings quality comparison for NanJing Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see NanJing Pharmaceutical Co Ltd market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.87x | CN¥2.14 Billion | CN¥743.12 Million | ▼ -12.9% |
| 2023 | 3.30x | CN¥1.91 Billion | CN¥577.83 Million | ▲ +446.2% |
| 2022 | -0.95x | CN¥-682.31 Million | CN¥715.92 Million | ▼ -183.7% |
| 2021 | 1.14x | CN¥695.33 Million | CN¥610.55 Million | ▲ +146.4% |
| 2020 | -2.45x | CN¥-1.15 Billion | CN¥470.04 Million | ▼ -205.4% |
| 2019 | 2.33x | CN¥1.00 Billion | CN¥431.55 Million | ▲ +319.3% |
| 2018 | -1.06x | CN¥-366.90 Million | CN¥345.83 Million | ▼ -194.3% |
| 2017 | 1.12x | CN¥319.99 Million | CN¥284.48 Million | ▲ +211.4% |
| 2016 | -1.01x | CN¥-240.88 Million | CN¥238.59 Million | ▲ +36.4% |
| 2015 | -1.59x | CN¥-306.08 Million | CN¥192.69 Million | ▲ +29.0% |
| 2014 | -2.24x | CN¥-341.01 Million | CN¥152.41 Million | ▲ +62.2% |
| 2013 | -5.92x | CN¥-354.27 Million | CN¥59.82 Million | ▼ -1710.5% |
| 2009 | 0.37x | CN¥20.22 Million | CN¥54.98 Million | ▲ +275.2% |
| 2008 | 0.10x | CN¥4.33 Million | CN¥44.15 Million | ▼ -91.4% |
| 2007 | 1.14x | CN¥81.08 Million | CN¥71.34 Million | ▼ -78.5% |
| 2006 | 5.28x | CN¥161.31 Million | CN¥30.55 Million | ▼ -3.8% |
| 2005 | 5.49x | CN¥165.57 Million | CN¥30.18 Million | ▲ +431.0% |
| 2004 | 1.03x | CN¥16.26 Million | CN¥15.74 Million | ▲ +88.1% |
| 2003 | 0.55x | CN¥19.27 Million | CN¥35.08 Million | ▼ -71.4% |
| 2002 | 1.92x | CN¥68.75 Million | CN¥35.82 Million | ▲ +1970.1% |
| 2001 | -0.10x | CN¥-4.20 Million | CN¥40.95 Million | ▼ -105.7% |
| 2000 | 1.81x | CN¥87.68 Million | CN¥48.53 Million | ▲ +170.4% |
| 1999 | 0.67x | CN¥50.58 Million | CN¥75.69 Million | ▼ -47.9% |
| 1998 | 1.28x | CN¥77.45 Million | CN¥60.44 Million | — |